# Dalteparin

## FRAGMIN 10000 IU(Anti-Xa)/4mL(洗腎室專用)

| TAH Drug Code      | [IFRA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IFRA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 1. Treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients for whom thrombolysis or surgical intervention is not suitable. 2. Prevention of coagulation during hemodialysis and hemofiltration. 3. Prevention of venous thrombosis in patients with temporarily restricted mobility due to acute conditions associated with increased thrombotic risk， such as heart failure， respiratory failure， or severe infections. 4. Treatment of acute deep vein thrombosis， pulmonary embolism， and cancer-associated thromboembolism， as well as prevention of recurrence.                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | Thrombolysis or treatment of acute deep vein thrombosis and pulmonary embolism not suitable for surgical treatment: SC once daily 200 IU/kg or twice daily 100 IU/kg， up to 18000 IU. Prophylaxis of coagulation during hemodialysis and hemofiltration， IV initial dose of 30-40 IU/kg then 10-15 IU/kg every hour. Prophylaxis to patients with substantially increased risk of venous thromboembolism & that are temporarily immobilized due to acute illness such as cardiac/respiratory insufficiency， severe infections 5000 IU SC once daily for 12-14 days or longer in patients with restricted mobility. Treatment of acute deep venous thrombosis & pulmonary embolism & extended thromboprophylaxis in cancer patients 200 IU/kg SC once daily for first month of treatment. Maximum daily dose: 18，000 IU . 150 IU/kg SC once daily for months 2-6.                                                                                                                    |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | ‧ History of confirmed or suspected immune-mediated heparin-induced thrombocytopenia (HIT). ‧ Clinically significant bleeding (e.g.， gastrointestinal ulceration or bleeding， intracranial hemorrhage). ‧ Severe coagulation disorders. ‧ Acute or subacute septic endocarditis. ‧ Recent trauma or surgery involving the central nervous system， eyes， and/or ears. ‧ Hypersensitivity to dalteparin， other low molecular weight heparins， heparin， or pork-derived products. ‧ In patients requiring high-dose dalteparin treatment (e.g.， for acute deep vein thrombosis， pulmonary embolism， or unstable coronary artery disease)， its use is contraindicated in those undergoing spinal or epidural anesthesia or other spinal puncture procedures due to the increased risk of bleeding. ‧ In patients undergoing epidural or neuraxial anesthesia do not administer dalteparin for unstable angina， non-Q-wave myocardial infarction， or prolonged VTE prophylaxis. |
| Adverse Effects    | Reversible non-immunologically-mediated thrombocytopenia (type 1)， transient elevation of liver transaminases， bleeding， hematoma at inj site， allergic reactions， pain at inj site. Dermatologic: Hematoma， Injection site (7% to 35%)， Injection site pain (4.5% to 12% ) Hematologic: Hematoma Other: Irritation symptom， Local                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/dalteparin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

## Fragmin inj 5000 IU/0.2mL single dose syringe

| TAH Drug Code      | [IFRA5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IFRA5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 1. Thrombosis prevention related to surgery. 2. Prevention of venous thrombosis in patients with temporary immobilization due to acute conditions， such as heart failure， respiratory failure， or severe infections， which increase the risk of venous thromboembolism. 3. Treatment of acute deep vein thrombosis (DVT)， pulmonary embolism (PE)， and prevention of recurrence in cancer patients with a history of thromboembolism.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Dosing             | Prophylaxis of venous thromboembolism during surgical procedures: Usually: 2500 IU given 2 hours before the procedure followed by 2500 IU once daily for 5-7 days or until the patient is fully ambulant. High-risk patients: 2500 IU given 2 hours before and 8-12 hours after the procedure， and followed by 5000 IU daily for 5-10 days. Or 5000 IU single dose in the evening before the procedure， and followed by 5000 IU every evening 5-10 days. Orthopedic surgery (for example， hip replacement surgery): up to 5 weeks. 5000 IU given in the evening before surgery followed by 5000 IU each subsequent evening. Or 2500 IU given 2 hours before and 8-12 hours after the procedure， and followed by 5000 IU daily. Or 2500 IU 4-8 hours after the procedure， and followed by 5000 IU daily. Venous thromboembolism Initial， 200 IU/kg every 24 hours for the first 30 days， followed by 150 IU/kg(= or <56kg: 7500 IU; 57-68kg:10000 IU; 69-82kg: 12500 IU; 83-98kg: 15000 IU; > or =99kg: 18000 IU) every 24 hours during months 2 to 6; Maximum daily dose， 18000 IU/day. Deep venous thrombosis， In medical patients with severely restricted mobility due to acute illness; Prophylaxis 5000 IU once daily for 12 to 14 days. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | ‧ Documented or suspected history of heparin-induced thrombocytopenia (HIT) caused by an immune reaction. ‧ Clinically significant bleeding (e.g.， gastrointestinal ulcer or bleeding， or cerebral hemorrhage). ‧ Severe coagulation disorders. ‧ Acute or subacute bacterial endocarditis. ‧ Recent trauma or surgery involving the central nervous system， eyes， and/or ears. ‧ Known hypersensitivity to dalteparin， other low molecular weight heparins， heparin， or pork-derived products. ‧ Due to an increased risk of bleeding， high doses of dalteparin (e.g.， for the treatment of acute deep vein thrombosis [DVT]， pulmonary embolism [PE]， or unstable coronary artery disease) should not be used in patients undergoing spinal or epidural anesthesia or other spinal puncture procedures.                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Common Dermatologic: Contusion (12% )， Hematoma， Injection site (7% to 35%)， Injection site bruising (30% )， Injection site pain (4.5% to 12% ) Respiratory: Bleeding from nose (10% ) Other: Irritation symptom， Local Serious Hematologic: Extradural intracranial hematoma， Hematoma， Spinal， Hemorrhage， Major (Up to 13.6%)， Hemorrhagic cerebral infarction (8% )， Intracranial hemorrhage， Subdural hemorrhage， Intrauterine， Thrombocytopenia (Adult， non-cancer indications， less than 1%; patients with cancer， 10.9% to 13.6% ; pediatric， 21% ) Hepatic: Increased liver function test (up to 4.3%) Immunologic: Anaphylactoid reaction (rare) Neurologic: Paralysis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/dalteparin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

